P F
1 Jan, 2019

Policies recently reviewed for annual update

The following policies were recently reviewed for annual update. The full text of these policies is available in the Provider section of bcbsri.com.            

    • Absorbable Nasal Implants for the Treatment of Nasal Valve Collapse
    • Actigraphy
    • Autism Spectrum Disorder Mandate – Updated with 2019 codes
    • Autologous Platelet Derived Growth Factors
    • Bone Mineral Density Studies
    • Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
    • Genetic Testing for Diagnosis and Management of Mental Health Conditions
    • Injectable Fillers
    • Lysis of Epidural Adhesions
    • Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders
    • Microvolt T-wave Alternans (MTWA)
    • Minimally Invasive Intradiscal and Annular Procedures for Back Pain
    • Non-Wearable Automatic External Defibrillator
    • Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
    • PathFinderTG® Molecular Testing
    • Patient-Controlled End of Range Motion Stretching Devices
    • Pediatric Dental Essential Services
    • Preventive Services: BlueCHiP for Medicare
    • Proprietary Laboratory Analyses (PLA)
    • Proteogenomic Testing for Patients with Cancer
    • Psychological and Neuropsychological Testing - Updated with 2019 codes
    • Saturation Biopsy in the Diagnosis, Staging and Management of Prostate Cancer
    • Serum Tumor Markers for Breast and Gastrointestinal Malignancies
    • Telemedicine Services Effective 01|01|2019
    • Total Arthroplasty Hip-Knee
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization
    • Ultrasonographic Measurement of Carotid Intima-Medical Thickness as an Assessment of subclinical Atherosclerosis
    • Vertebral Fracture Assessment